Abstract:Abstract BACKGROUND The IL-17 superfamily, which mediates cross-talk between the adaptive and innate immune systems, has been associated with severity of asthma. The role of miRNAs in the disease has been paid much attention. To explore the roles of IL-17 in asthma and the relationship between IL-17 and miRNAs, we used a model of severe asthma driven by chronic respiratory exposure to house dust mite (HDM) exposure in wild type and IL-17KO mice, followed with miRNA profiling assays and analysis.METHODS Male and female C57BL/6 mice (6-8 weeks old) and IL-17KO mice (C57BL/6 background) were exposed to purified HDM extract intranasally for 5 days/week for 5 consecutive weeks. Sterile saline was used as the control. The parameters including airway responsiveness, inflammatory cells in bronchoalveolar lavage fluid (BALF), airway smooth muscle bundle, collagen deposition, and cytokine levels in BALF were examined. The miRNA profile of mouse lung tissue was analyzed by microarray assays. The dysregulation of miRNA related to IL-17 and asthma was validated by qRT-PCR. The in vitro cell culture experiment was performed to confirm the relationship between IL-17 and selected miRNA. The regulation of miRNA on predicted target gene was validated by administration of miRNA mimics. RESULTS The expression of IL-17A significantly increased in wild type (WT) mice with HDM exposure compared to the control mice. IL-17 deficiency did not reduce airway hyper responsiveness (AHR) induced by HDM exposure. In comparison to HDM-exposed WT mice, BALF neutrophils in IL-17KO mice were significantly decreased. In WT mice, HDM exposure led to increased expression of IL-4 and KC, which was significantly decreased in IL-17KO mice. Furthermore, under HDM exposure, significantly less airway smooth muscle mass and collagen deposition was found in IL-17KO mice compared to WT mice. In the dysregulated miRNAs, the decreased expression of miR-365-3p in HDM-exposed WT mice was validated, and its expression recovered in IL-17KO mice. Furthermore, miR-365-3p was decreased in mouse alveolar epithelial cells by IL-17 treatment. The transfection of miR-365-3p mimics decreased the expression of predicted target gene ARRB2.

Microrna-143 Downregulates Interleukin-13 Receptor Alpha1 In Human Mast Cells

Mir-143 Inhibits Interleukin-13-induced Inflammatory Cytokine and Mucus Production in Nasal Epithelial Cells from Allergic Rhinitis Patients by Targeting IL13Rα1

IL-27 Signaling Negatively Regulates FcɛRI-mediated Mast Cell Activation and Allergic Response

Down-regulation of miR-140-3p is a cause of the interlukin-13-induced up-regulation of RhoA protein in bronchial smooth muscle cells

Micro RNA-17-92 Cluster Mediates Interleukin-4-suppressed IL-10 Expression in B Cells.

Intranasal Administration of Lentiviral miR-135a Regulates Mast Cell and Allergen-Induced Inflammation by Targeting GATA-3

Interleukin-33 mediated regulation of microRNAs in human cord blood-derived mast cells: Implications for infection, immunity, and inflammation

Down-Regulation of Mir-146A Expression Induces Allergic Conjunctivitis in Mice by Increasing TSLP Level

Epithelial Cell-Derived Micro RNA-146a Generates Interleukin-10-producing Monocytes to Inhibit Nasal Allergy.

Mir-511-3p Limits Allergic Inflammation Through M2 Macrophage Polarization And Modulating Ccl2 Expression

MiR-193b-3p Regulates TLR4 Expression to Inhibit Inflammation by Targeting ETS1 in Allergic Rhinitis.

MiR-365-3p is a negative regulator in IL-17-mediated asthmatic inflammation

IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell Function

MicroRNA-126 Accelerates IgE-mediated Mast Cell Degranulation Associated with the PI3K/Akt Signaling Pathway by Promoting Ca2+ Influx

MicroRNA-146a downregulates interleukin-13 and inhibits the proliferation of human periodontal ligament stem cells

Regulatory Effect of Microrna-135A on the Th1/Th2 Imbalance in a Murine Model of Allergic Rhinitis.

Increased Mir-223-3p in Leukocytes Positively Correlated with IL-17A in Plasma of Asthmatic Patients

Altered Microrna Expression Profiles In Activated Mast Cells Following Ige-Fc Epsilon Ri Cross-Linking With Antigen

MiR-365-3p is Involved in IL17-Mediated Asthma in Mouse Model

Microrna-22-3p Plays A Protective Role In A Murine Asthma Model Through The Inhibition Of The Nlrp3-Caspase-1-Il-1 Beta Axis

MicroRNA-145 Influences the Balance of Th1/Th2 Via Regulating RUNX3 in Asthma Patients